CRMD Soars 19.40% as CorMedix Announces Preliminary Q1 Results and Raises H1 Guidance, But Will the Momentum Continue?
The biotech sector has been on fire lately, with several stocks making significant gains in recent days. One stock that’s caught my attention is CRMD, which has surged 19.40% today as of the time of writing after it announced preliminary first quarter results and raised guidance for the first half of fiscal year 2025. CorMedix … Read more